Lymph node assessment and lymphadenectomy in bladder cancer

Journal of Surgical Oncology

Volumn 99, Issue 4, 2009, Pages 225-231

  Sharir, Sharon ^a,b,d   Fleshner, Neil E ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HUMBER RIVER REGIONAL HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d NONE   (Canada)

Author keywords

Pelvic lymph node dissection; Radical cystectomy

Indexed keywords

BLADDER CANCER; CANCER STAGING; CYSTECTOMY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE;

EID: 62749126706     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21253     Document Type: Review

References (71)

1. Canadian Cancer Statistics 2008. Toronto: Canadian Cancer Society/National Cancer Institute of Canada. 2008 [cited December 13, 2008]. Available from: http://www.cancer.ca/Canada-wide/About%20cancer/ Cancer%20statistics/Canadian%20Cancer%20Statistics.aspx?sc-lang=en.
2. Schned AR, Andrew AS, Marsit CJ, et al.: Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scand J Urol Nephrol 2008;42:237-242.
3. Larsson P, Wijkström H, Thorstenson A, et al.: A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J Urol Nephrol 2003;37:195-201.
4. Holmäng S, Hedelin H, Anderström C, et al.: Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period. Scand J Urol Nephrol 2000;34:95-101.
5. Kurtz GA, McKinney JL, Law CHL, et al.: Toward quality measures in bladder cancer surgery: A population-based assessment of radical cystectomy in Ontario. J Urol 2008;179 (4 supp):581.
6. Konety BR, Joslyn SA: Factors influencing aggressive therapy for bladder cancer: An analysis of data from the SEER program. J Urol 2003;170:1765-1771.
7. Stein JP, Skinner DG: The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin North Am 2005;32:187-197.
8. Karakiewicz PI, Shariat SF, Palapattu GS, et al.: Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 2006;176:1354-1361.
9. International Bladder Cancer Nomogram Consortium. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006;24:3967-3972.
10. Kerr WS, Colby FH: Pelvic lymph node dissection and total cystectomy in the treatment of carcinoma of the bladder. J Urol 1950;63:842-851.
11. Skinner DG: Management of invasive bladder cancer: A meticulous pelvic node dissection can make a difference. J Urol 1982;128:34-36.
12. Herr HW, Donat SM: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 2001;165:62-64.
13. Thompson IM: Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 2001;166:630.
14. Schoenberg MP, Gonzalgo ML: Chapter 77: Management of invasive and metastatic bladder cancer. In: Wein JE, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th edition. Philadelphia, PA: Saunders Elsevier; 2007. pp. 2468-2478.
15. Wittekind Ch, Greene FL, Henson DE, et al.: TNM supplement: A commentary on uniform use. 3rd edition. New York: Wiley-Liss; 2003.
16. Greene FL, Page DL, Fleming ID, et al.: AJCC cancer staging manual. 6th edition. New York: Springer; 2002.
17. Nieh PT, Marshall FF: Chapter 78: Surgery of bladder cancer. In: Wein JE, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th edition. Philadelphia, PA: Saunders Elsevier; 2007.pp. 2479-2505.
18. Sobin LH, Wittekind Ch: TNM Classification of malignant tumours. 6th edition. New York: Wiley-Liss; 2002.
19. Marits P, Karlsson M, Sherif A, et al.: Detection of immune responses against urinary bladder cancer in sentinel lymph nodes. Eur Urol 2006;49:59-70.
20. Mills RD, Turner WH, Fleischmann A, et al.: Pelvic lymph node metastases from bladder cancer: Outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 2001;166:19-23.
21. Leissner J, Ghoneim MA, Abol-Enein H, et al.: Extended radical lymphadenectomy in patients with urothelial bladder cancer: Results of a prospective multicenter study. J Urol 2004;171:139-144.
22. Herr HW, Faulkner JR, Grossman HB, et al.: Pathologic evaluation of radical cystectomy specimens - A cooperative group report. Cancer 2004;100:2470-2475.
23. Sharir S: Toward quality measures in bladder cancer surgery: A population based assessment of radical cystectomy in Ontario, unpublished data.
24. Steven K, Poulsen AL: Radical cystectomy and extended pelvic lymphadenectomy: Survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only. J Urol 2007;178:1218-1224.
25. Shariat SF, Karakiewicz PI, Palapattu GS, et al.: Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the bladder cancer research consortium. J Urol 2006;176:2414-2422.
26. Stein JP, Lieskovsky G, Cote R, et al.: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 2001;19:666-675.
27. Madersbacher S, Hochreiter W, Burkhard F, et al.: Radical cystectomy for bladder cancer today-A homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;21:690-696.
28. Bassi P, Ferrante GD, Piazza N, et al.: Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort. J Urol 1999;161:1494-1497.
29. Bella AJ, Stitt LW, Chin JL, et al.: The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder. J Urol 2003;170:2253-2257.
30. Ghoneim MA, Abdel-Latif M, El-Mekresh M, et al.: Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 2008;180:121-127.
31. Stein JP, Cai J, Groshen S, et al.: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: The concept of lymph node density. J Urol 2003;170:35-41.
32. Herr HW, Bochner BH, Dalbagni G, et al.: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002;167:1295-1298.
33. Fleischmann A, Thalmann GN, Markwalder R, et al.: Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol 2005;29:89-95.
34. Vieweg J, Gschwend JE, Herr HW, et al.: Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999;161:449-454.
35. Kassouf W, Leibovici D, Luongo T, et al.: Relevance of extracapsular extension of pelvic lymph node metastasis in patients with bladder cancer treated in the contemporary era. Cancer 2006;107:1491-1495.
36. Konety BR, Joslyn SA, O'Donnell MA: Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: Analysis of data from the Surveillance, Epidemiology and End Results program data base. J Urol 2003;169:946-950.
37. Herr HW: The concept of lymph node density - Is it ready for clinical practice? J Urol 2007;177:1273-1275.
38. Ruggeri EM, Giannarelli D, Bria E, et al.: Adjuvant chemotherapy in muscle-invasive bladder carcinoma: A pooled analysis from phase III studies. Cancer 2006;106:783-788.
39. Vale CL: Advanced Bladder Cancer Meta-analysis Collaboration. Adjuvant chemotherapy for invasive bladder cancer (individual patient data). Cochrane Database Systematic Rev 2006;2:Art. No.: CD006018. DOI: 10.1002/14651858. CD006018.
40. Montie JE: Improving outcomes after radical cystectomy. J Urol 2008;180:12-13.
41. Herr HW, Faulkner JR, Grossman HB, et al.: Surgical factors influence bladder cancer outcomes: A cooperative group report. J Clin Oncol 2004;22:2781-2789.
42. Poulsen AL, Horn T, Steven K: Radical cystectomy: Extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998;160:2015-2020.
43. Dhar NB, Klein EA, Reuther AM, et al.: Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008;179:873-878.
44. Sherif A, de la Torre M, Malmström PU, et al.: Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol 2001;166:812-815.
45. Liedberg F, Chebil G, Davidsson T, et al.: Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol 2006;175:84-89.
46. Vazina A, Dugi D, Shariat SF, et al.: Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004;171:1830-1834.
47. Bochner BH, Herr HW, Reuter VE: Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001;166:2295-2296.
48. Leissner J, Hohenfellner R, Thüroff JW, et al.: Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; Significance for staging and prognosis. BJU Int 2000;85:817-823.
49. Abol-Enein H, El-Baz M, Abd El-Hameed MA, et al.: Lymph node involvement in patients with bladder cancer treated with radical cystectomy: A patho-anatomical study - A single center experience. J Urol 2004;172:1818-1821.
50. Bochner BH, Cho D, Herr HW, et al.: Prospectively packaged lymph node dissections with radical cystectomy: Evaluation of node count variability and node mapping. J Urol 2004;172:1286-1290.
51. Neulander EZ: Re: Pelvic lymph node metastases from bladder cancer: Outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 2002;167:651.
52. Brössner C, Pycha A, Toth A, et al.: Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 2004;93:64-66.
53. Herr H, Lee C, Chang S, et al.: Bladder Cancer Collaborative Group. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: A collaborative group report. J Urol 2004;171:1823-1828.
54. Wright JL, Lin DW, Porter MP: The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer 2008;112:2401-2408.
55. Gilbert SM: Separating surgical quality from causality-gaining perspective in the debate on lymph node count and extent of lymphadenectomy. Cancer 2008;112:2331-2333.
56. Weingärtner K, Ramaswamy A, Bittinger A, et al.: Anatomical basis for pelvic lymphadenectomy in prostate cancer: Results of an autopsy study and implications for the clinic. J Urol 1996;156:1969-1971.
57. Kulkarni GS, Finelli A, Lockwood G, et al.: Effect of healthcare provider characteristics on nodal yield at radical cystectomy. Urology 2008;72:128-132.
58. Huang WC, Bochner BH: Current status of establishing standards for lymphadenectomy in the treatment of bladder cancer. Curr Opin Urol 2005;15:315-319.
59. Herr HW: Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003;61:105-108.
60. Stein JP, Penson DF, Cai J, et al.: Radical cystectomy with extended lymphadenectomy: Evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 2007;177:876-882.
61. Koren R, Paz A, Lask D, et al.: Lymph-node revealing solution: A new method for detecting minute lymph nodes in cystectomy specimens. B J Urol 1997;80:40-43.
62. Amin MB, Srigley JR, Grignon DJ, et al.: Urinary bladder, ureter, and renal pelvis cancer protocol, revised January 2005. College of American Pathologists [cited December 13, 2008]. Available from: http://www.cap.org/apps/ docs/committees/cancer/cancer-protocols/2005/urbladder05-pw.pdf.
63. Hollenbeck BK, Ye Z, Wong SL, et al.: Hospital lymph node counts and survival after radical cystectomy. Cancer 2008;112:806-812.
64. Ide H, Kikuchi E, Miyajima A, et al.: The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer. Jpn J Clin Oncol 2008;38:360-364.
65. Koppie TM, Vickers AJ, Vora K, et al.: Standardization of pelvic lymphadenectomy performed at radical cystectomy: Can we establish a minimum number of lymph nodes that should be removed? Cancer 2006;107:2368-2374.
66. Suttmann H, Kamradt J, Lehmann J, et al.: Improving the prognosis of patients after radical cystectomy. Part I: The role of lymph node dissection. BJU Int 2007;100:1221-1224.
67. Gofrit ON, Zorn KC, Steinberg GD, et al.: The Will Rogers phenomenon in urological oncology. J Urol 2008;179:28-33.
68. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-1608.
69. Sherif A, Garske U, de la Torre M, et al.: Hybrid SPECT-CT: An additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 2006;50:83-91.
70. Knapp DW, Adams LG, Degrand AM, et al.: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 2007;52:1700-1708.
71. Lerner SP: Editorial comment on: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 2007;52:1708-1709.